FIT
FIT is an intervention with 12 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
5
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
FIT Families Multicomponent Obesity Intervention for African American Adolescents
China Colorectal Cancer Screening Trial 1 (C-Cost1)
Clinical Trials (12)
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
FIT Families Multicomponent Obesity Intervention for African American Adolescents
China Colorectal Cancer Screening Trial 1 (C-Cost1)
China Colorectal Cancer Screening Trial 2 (C-Cost2)
A Study on a Blood-based Dual-target Test for CRC Detection
Combining Risk Factors and Faecal Immunochemical Testing in Colorectal Cancer Screening: a Randomized Controlled Trial
Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China
Colorectal Cancer Screening Using Stool DNA-based SDC2 and SFRP2 Methylation Test in China
Clinical Trial of Abstinence-Linked Money Management
Screening for Colorectal Cancer in Average and High Risk Population
All 12 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 12